U.S. President Joe Biden signed an executive order on 9 March 2022 to direct federal agencies to examine potential regulatory changes as well as the risks and benefits posed by cryptocurrencies.
ASIC introduced a product intervention order (Order) in October 2020, imposing restrictions on the issue and distribution of contracts for difference (CFDs) to retail investors. This decision came after the regulator’s finding that CFDs have resulted in, and are likely to result in, significant detriment to retail investors.
Are you aware of the penalties for non-compliance with ASIC’s trade reporting rules? Australian entities dealing in OTC derivatives are required to report under and comply with the ASIC Derivative Transaction Rules
The commencement of ASIC’s Product Intervention Order (Order) in respect of CFDs requires no action from you in respect of your OTC derivatives transaction reporting to ASIC.
DTCC recently announced the termination of their vendor relationship with Refinitiv, operators of Avox Limited. Underpinning the termination of DTCC’s vendor relationship with Refinitiv is the significant reduction in the use of AVIDs as the global community shifts towards the adoption of an Legal Entity Identifier (LEI) only policy.
ASIC registered an extension to its existing instruments to extend its previous relief. Some elements were continued, whilst others were removed. We take a look at what exemptions are still available from the ASIC Derivative Transaction Reporting Rules.
ASIC recently issued infringement notices with fines to AMP Life Limited (AMP Life) and AMP Capital Investors Limited (AMP Capital) based on alleged contraventions. The total fines were $526,000. What can we learn from this incident?
ASIC has granted conditional relief from use of Unique Trade Identifiers (UTI) for another 2.5 years.
There are 3 forms of LEI relief available for firms to rely on, depending on the client or counterparty’s location.